BridgeBio Pharma BBIO Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's other income (expense)?
- BridgeBio Pharma (BBIO) reported other income (expense) of -$60.6M in Q1 2026.
- How has BridgeBio Pharma's other income (expense) changed year-over-year?
- BridgeBio Pharma's other income (expense) increased by 7.1% year-over-year, from -$65.24M to -$60.6M.
- What does other income (expense) mean?
- The net total of all income and expenses that are not related to the company's primary business operations.
- How do you interpret other income (expense)?
- A positive value indicates net non-operating income, while a negative value indicates a net drag from financing or other non-core activities.
- How does other income (expense) compare across companies?
- Varies widely based on the company's debt load and cash management strategy.